Evidence-Based Medicine Guidelines
Recombinant luteinizing hormone (rLH) for ovarian hyperstimulation
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Recombinant Luteinizing Hormone (rLH) for Ovarian Hyperstimulation." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/455015/all/Recombinant_luteinizing_hormone__rLH__for_ovarian_hyperstimulation.
Recombinant luteinizing hormone (rLH) for ovarian hyperstimulation. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/455015/all/Recombinant_luteinizing_hormone__rLH__for_ovarian_hyperstimulation. Accessed June 4, 2023.
Recombinant luteinizing hormone (rLH) for ovarian hyperstimulation. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/455015/all/Recombinant_luteinizing_hormone__rLH__for_ovarian_hyperstimulation
Recombinant Luteinizing Hormone (rLH) for Ovarian Hyperstimulation [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 June 04]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/455015/all/Recombinant_luteinizing_hormone__rLH__for_ovarian_hyperstimulation.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Recombinant luteinizing hormone (rLH) for ovarian hyperstimulation
ID - 455015
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/455015/all/Recombinant_luteinizing_hormone__rLH__for_ovarian_hyperstimulation
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
